Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GT Biopharma, Inc. has filed 868 SEC EDGAR filings since 12 May 1995

SEC filing history

Showing 401-425 of 509 matching filings.

Per page
25
Current page
17
SC 13G/A File 005-32837

AMENDMENT NO. 7

Filing date
05 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-08092

ANNUAL REPORT

Filing date
30 Mar 2016
Reporting date
31 Dec 2015
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
02 Mar 2016
Reporting date
09 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
23 Feb 2016
Reporting date
25 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

OXIS 8-K AMENDMENT OF NOTE CONVERSION AGREEMENT

Filing date
19 Feb 2016
Reporting date
19 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-32837

NONE

Filing date
18 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
12 Feb 2016
Reporting date
25 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-32837

NONE

Filing date
09 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-32837

SCHEDULE 13G

Filing date
26 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-32837

AMENDED SCHEDULE 13D

Filing date
26 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
25 Jan 2016
Reporting date
13 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-32837

SCHEDULE 13G AMENDMENT

Filing date
25 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

OXIS 8-K SALE OF UNREGISTERED SECURITIES

Filing date
22 Jan 2016
Reporting date
19 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
08 Jan 2016
Reporting date
08 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
13 Nov 2015
Reporting date
30 Sep 2015
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
26 Oct 2015
Reporting date
26 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

OXIS 8-K DR. VALLERA LICENSE

Filing date
08 Sep 2015
Reporting date
03 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
14 Aug 2015
Reporting date
30 Jun 2015
Next action
Verify source filing
D File 021-244451

D filing

Filing date
27 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-08092

OXIS DEF 14C

Filing date
19 May 2015
Reporting date
19 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
14 May 2015
Reporting date
31 Mar 2015
Next action
Verify source filing
PRE 14C File 000-08092

OXIS PRE 14C

Filing date
08 May 2015
Reporting date
08 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-08092

OXIS INTERNATIONAL ANNUAL REPORT 2014

Filing date
31 Mar 2015
Reporting date
31 Dec 2014
Next action
Verify source filing
D File 021-235943

D filing

Filing date
16 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

OXIS 8-K FILED MARCH 13, 2015

Filing date
13 Mar 2015
Reporting date
10 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .